![Sukumar Sakamuri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Sukumar Sakamuri
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sukumar Sakamuri via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rochester Christian University | College/University | Doctorate Degree | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
University of California, Los Angeles | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Undergraduate Degree | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Center for Drug Evaluation & Research | General Government | Director/Board Member | |
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director/Board Member | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ANNEXON, INC. | Pharmaceuticals: Major | Private Equity Investor | |
REGENETP, INC. | Biotechnology | Director/Board Member | |
California Society of Certified Public Accountants | Corporate Officer/Principal | ||
The American Institute of Certified Public Accountants
![]() The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
VIELA BIO, INC. | Biotechnology | Director/Board Member | |
San Diego State University | College/University | Undergraduate Degree | |
CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
NiKang Therapeutics, Inc.
![]() NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
GUARDANT HEALTH, INC. | Medical/Nursing Services | Private Equity Investor | |
Proteus Digital Health, Inc.
![]() Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MOLECULIN BIOTECH, INC. | Director/Board Member | ||
CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
China Medical University | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Doctorate Degree | |
American Association for Cancer Research
![]() American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fudan University | College/University | Undergraduate Degree | |
ERASCA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
TRANSCENTA HOLDING LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Duke Capital Partners LLC
![]() Duke Capital Partners LLC Investment ManagersFinance Duke Capital Partners, LLC provides financial advisory, investment, and equity services. The company was founded in 2000, and is headquartered in Charlotte, NC. | Investment Managers | Corporate Officer/Principal | |
Berkeley Frontier Fund
![]() Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Investment Managers | Consultant / Advisor | |
Ggtg Biosciences, Inc.
![]() Ggtg Biosciences, Inc. Investment ManagersFinance GGTG Biosciences Inc (GGTG Biosciences) is a venture capital firm founded in 2022 by Gary Yeung. The firm is headquartered in Burlingame, California. | Investment Managers | Chief Executive Officer | |
Stealth Startup Solutions LLC
![]() Stealth Startup Solutions LLC Miscellaneous Commercial ServicesCommercial Services Stealth Startup Solutions LLC engages in provision of consulting services. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder | |
Stanford School of Medicine | College/University | Consultant / Advisor | |
Xilis, Inc.
![]() Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Director of Finance/CFO | |
ARCELLX, INC. | Biotechnology | Director/Board Member | |
Davidson College | College/University | Undergraduate Degree | |
The University of North Carolina at Chapel Hill | College/University | Masters Business Admin | |
Ymmunobio AG
![]() Ymmunobio AG BiotechnologyHealth Technology Ymmunobio AG is a Swiss preclinical stage oncology biotech company that develops innovative treatments for cancer patients through new classes of antibodies. The company is based in Riehen, Switzerland. The company focuses on high unmet need indications in gastro-intestinal cancers, making extensive progress in developing first-in-class or novel class of antibodies that have the potential to overcome resistance of cancer patients to current available therapies. Ymmunobio's research is based on their deep understanding of immuno-oncology and precision cancer treatments, leveraging their profound knowledge of biologics while selecting the optimal approach to developing transformative therapeutics across cancer indications. The company was founded in 2021 by Katrin Rupalla. The CEO is Peter Schiemann. | Biotechnology | Founder | |
Bristol-Myers Squibb Holdings Ltd.
![]() Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Miscellaneous | Corporate Officer/Principal | |
Jones International University | College/University | Masters Business Admin | |
Philipps University of Marburg | College/University | Doctorate Degree | |
4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Speedel Pharma AG
![]() Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | General Counsel |
Statistiques
Internationale
Etats-Unis | 34 |
Royaume-Uni | 5 |
Chine | 4 |
Allemagne | 3 |
Suisse | 3 |
Sectorielle
Health Technology | 20 |
Consumer Services | 13 |
Commercial Services | 7 |
Finance | 5 |
Government | 2 |
Opérationnelle
Director/Board Member | 31 |
Corporate Officer/Principal | 19 |
Independent Dir/Board Member | 15 |
Chief Tech/Sci/R&D Officer | 10 |
Director of Finance/CFO | 7 |
Relations les plus connectées
Insiders | |
---|---|
Christian Nolet | 15 |
Jakob Dupont | 14 |
Sonja Nelson | 13 |
Katrin Rupalla | 13 |
Gary Yeung | 13 |
Olivia Ware | 10 |
Joy Yan | 8 |
Yi Gu | 6 |
- Bourse
- Insiders
- Sukumar Sakamuri
- Connexions Sociétés